UMIN ID: UMIN000002320
Registered date:11/08/2009
The prediction study of the effect of antibody therapy using antibody dependent cell-mediated cytotoxicity with blood sample
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | malignant solid tumor |
| Date of first enrollment | 2009/06/01 |
| Target sample size | 150 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | the predict of clinical outcome and adverse effect |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | * patients determined ineligible for this study by the researcher |
Related Information
| Primary Sponsor | national cancer center |
|---|---|
| Secondary Sponsor | Hitachi Chemical |
| Source(s) of Monetary Support | national cancer center |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Kenji Tamura |
| Address | Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan Japan |
| Telephone | 03-3541-2511 |
| NCC_IRBoffice@ml.res.ncc.go.jp | |
| Affiliation | national cancer center breast and medical onoclogy division |
| scientific contact | |
| Name | Yasuhiro Fujiwara |
| Address | Tsukiji 5-1-1, Chuo-ku, Tokyo, Japan Japan |
| Telephone | 03-3541-2511 |
| Affiliation | national cancer center breast and medical onoclogy division |